The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
Open accessAbstract
The pathogenesis of type 2 diabetes involves abnormalities in insulin action, insulin secretion, and endogenous glucose output (EGO). However, the sequence with which these abnormalities develop and their relative contributions to the deterioration in glucose tolerance remain unclear in the absence of a detailed longitudinal study. We measured insulin action, insulin secretion, and EGO longitudinally in 17 Pima Indians, in whom glucose tolerance deteriorated from normal (NGT) to impaired (IGT) to diabetic over 5.1 +/- 1.4 years. Transition from NGT to IGT was associated with an increase in body weight, a decline in insulin-stimulated glucose disposal, and a decline in the acute insulin secretory response (AIR) to intravenous glucose, but no change in EGO. Progression from IGT to diabetes was accompanied by a further increase in body weight, further decreases in insulin-stimulated glucose disposal and AIR, and an increase in basal EGO. Thirty-one subjects who retained NGT over a similar period also gained weight, but their AIR increased with decreasing insulin-stimulated glucose disposal. Thus, defects in insulin secretion and insulin action occur early in the pathogenesis of diabetes. Intervention to prevent diabetes should target both abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Insulin resistance and concurrent relative insulin deficiency and glucagon dysregulation underlie T2D pathophysiology.33–35”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [34]
Experimental — accuracy not yet measuredIn the citing paper
“These findings derived from cross-sectional data are supported by a longitudinal study in Pima Indians that has also shown the importance of accounting for the hyperbolic relationship between insulin sensitivity and insulin secretion and demonstrated the presence of impaired beta-cell function in those destined to progress to Type 2 diabetes [95].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Seventeen (35%) of these subjects progressed from NGT to IGT and then to diabetes during follow up.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Our finding of a hyperbolic relationship between insulin sensitivity and insulin secretion in healthy subjects has been confirmed in large cohorts of Danish [94] and Pima Indian subjects [95].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“During follow up, insulin secretion declined progressively by 78% while insulin sensitivity decreased by only 14%.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Based on the UKPDS [18] and the longitudinal assessment in Pima Indians [95], the major reason for the decline in glucose tolerance seems to be a progressive loss of beta-cell function.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Further progressive deterioration of β-cell function accounts for the evolving natural history of the disease from impaired glucose tolerance to type 2 diabetes10,11.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [10]
In the citing paper
“Our results may help explain the aforementioned association between N3 lack and T2DM, as a loss in first-phase insulin secretion is both an early marker of T2DM and part of its pathogenesis (20).”
From Sleep architecture and glucose and insulin homeostasis in obese adolescents (2011) · cites this paper as [20]
In the citing paper
“IGT and T2DM ensue when beta cell function fails to compensate.”
From The Vasculature in Prediabetes (2018) · cites this paper as [16]
In the citing paper
“Insulin resistance precedes the development of hyperglycemia and T2DM and results in compensatory hyperinsulinemia.”
From The Vasculature in Prediabetes (2018) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Coated Charcoal Immunoassay of Insulin
Herbert, V. D., Lau, K., Gottlieb, C. W., & Bleicher, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,969
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Body composition from fluid spaces and density: analysis of methods. 1961.
Siri, W. E. (1994) · PubMed · Cited by 2,556
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Pathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · cited 5×
“It is well known that there is a hyperbolic relationship between early insulin secretion and insulin action in individuals with NGT, meaning that, cross-sectionally, insulin secretion increases with decreasing insulin action and vice versa (51, 52).”
BackgroundMethodInfluentialTechniques for Measuring Body Composition
National Research Council (1961) · National Academies Press eBooks · doi:10.17226/21603 · Cited by 1,620
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
Self-citationShulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248
Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber.
Ravussin, E., Lillioja, S., Anderson, T. E., Christin, L., & Bogardus, C. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112749 · Cited by 1,166
Self-citationMartin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158
Ohlson, L., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,143
Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
Warram, J. H., Martin, B. C., Krolewski, A. S., Soeldner, J. S., & Kahn, C. R. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-909 · Cited by 1,038
Diabetes Mellitus: Report of a WHO Study Group.
(1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-4-597_2 · Cited by 1,030
Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach
Bergman, R. N. (1989) · Diabetes · doi:10.2337/diab.38.12.1512 · Cited by 1,001
Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes Mellitus
Eriksson, J., Franssila-Kallunki, A., Ekstrand, A., Saloranta, C., Widén, E., Schalin, C., & Groop, L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210601 · Cited by 807
(1997) · Diabetes reviews · Cited by 671
Diabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis
Knowler, W. C., Pettitt, D. J., Saad, M. F., & Bennett, P. H. (1990) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610060101 · Cited by 578
Impaired Glucose Tolerance as a Disorder of Insulin Action
Lillioja, S., Mott, D. M., Howard, B. V., Bennett, P. H., Yki-Järvinen, H., Freymond, D., Nyomba, B. L., Zurlo, F., Swinburn, B., & Bogardus, C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181901 · Cited by 578
Self-citationBrunzell, J. D., Robertson, R. P., Lerner, R. L., Hazzard, W. R., Ensinck, J. W., Bierman, E. L., & Porte, D. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-42-2-222 · Cited by 511
IMMUNOASSAY OF ENDOGENOUS PLASMA INSULIN IN MAN
Yalow, R. S., & Berson, S. A. (1996) · Obesity Research · doi:10.1002/j.1550-8528.1996.tb00274.x · Cited by 459
Ferrannini, E. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.4.0336 · Cited by 451
Gerich, J. E. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.4.0338 · Cited by 450
Familial Dependence of the Resting Metabolic Rate
Bogardus, C., Lillioja, S., Ravussin, E., Abbott, W., Zawadzki, J. K., Young, A., Knowler, W. C., Jacobowitz, R., & Moll, P. P. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607103150205 · Cited by 398
Self-citationBogardus, C., Lillioja, S., Howard, B. V., Reaven, G. M., & Mott, D. M. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111533 · Cited by 397
Self-citationMetabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study
Perseghin, G., Ghosh, S., Gerow, K., & Shulman, G. I. (1997) · Diabetes · doi:10.2337/diab.46.6.1001 · Cited by 367
Risk factors for worsening to diabetes in subjects with impaired glucose tolerance
Kadowaki, T., Miyake, Y., Hagura, R., Akanuma, Y., Kajinuma, H., Kuzuya, N., Takaku, F., & Kosáka, K. (1984) · Diabetologia · doi:10.1007/bf00252262 · Cited by 315
Insulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM?
Taylor, S. I., Accili, D., & Imai, Y. (1994) · Diabetes · doi:10.2337/diab.43.6.735 · Cited by 289
Gulli, G., Ferrannini, E., Stern, M., Haffner, S., & DeFronzo, R. A. (1992) · Diabetes · doi:10.2337/diab.41.12.1575 · Cited by 283
Cerasi, E., Luft, R., & Efendić, S. (1972) · Diabetes · doi:10.2337/diab.21.4.224 · Cited by 251
Natural History of β-Cell Dysfunction in NIDDM
Leahy, J. L. (1990) · Diabetes Care · doi:10.2337/diacare.13.9.992 · Cited by 246
Risk Factors for NIDDM in White Population: Paris Prospective Study
Charles, M.-A. A., Fontbonne, A., Thibult, N., Warnet, J., Rosselin, G., & Eschwège, É. (1991) · Diabetes · doi:10.2337/diab.40.7.796 · Cited by 241
A two-step model for development of non-insulin-dependent diabetes
Saad, M. F., Knowler, W. C., Pettitt, D. J., Nelson, R. G., Charles, M.-A. A., & Bennett, P. H. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80165-i · Cited by 233
Bruce, D. G., Chisholm, D. J., Storlien, L. H., & Kraegen, E. W. (1988) · Diabetes · doi:10.2337/diab.37.6.736 · Cited by 232
O’Rahilly, S., Rudenski, A. S., Burnett, M. A., Nugent, Z. J., Hosker, J. P., Darling, P., & Turner, R. C. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90052-8 · Cited by 229
Obesity and insulin resistance: Lessons learned from the Pima indians
Lillioja, S., & Bogardus, C. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040508 · Cited by 203
Self-citationLuzi, L., & DeFronzo, R. A. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.257.2.e241 · Cited by 186
Cowen, P. J., & Nutt, D. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90550-5 · Cited by 180
Reaven, G. M., Hollenbeck, C. B., & Chen, Y. I. (1989) · Diabetologia · doi:10.1007/bf00265404 · Cited by 179
Calles-Escandon, J., & Robbins, D. C. (1987) · Diabetes · doi:10.2337/diab.36.10.1167 · Cited by 154
Aspects of the Pathogenesis of Type 2 Diabetes*
Efendić, S., Luft, R., & Wajngot, A. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-3-395 · Cited by 153
OBESITY, VERY LOW DENSITY LIPOPROTEINS, AND GLUCOSE INTOLERANCE OVER FOURTEEN YEARS
Wilson, P. W. F., McGee, D., & Kannel, W. B. (1981) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113240 · Cited by 147
Chen, K.-W., Boyko, E. J., Bergstrom, R. W., Leonetti, D. L., Newell‐Morris, L. L., WAHL, P. W., & Fujimoto, W. Y. (1995) · Diabetes Care · doi:10.2337/diacare.18.6.747 · Cited by 144
Groop, L., Wid�n, E., & Ferrannini, E. (1993) · Diabetologia · doi:10.1007/bf00400814 · Cited by 136
Bogardus, C., Lillioja, S., Mott, D., Reaven, G. R., Kashiwagi, A., & Foley, J. E. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111274 · Cited by 131
Self-citationReduced insulin secretion: an independent predictor of body weight gain
Schwartz, M. W., Boyko, E. J., Kahn, S. E., Ravussin, É., & Bogardus, C. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.5.7745002 · Cited by 131
Self-citationDecreased insulin action and insulin secretion predict the development of impaired glucose tolerance
Haffner, S. M., Miettinen, H., GASKILL, S. P., & Stern, M. P. (1996) · Diabetologia · doi:10.1007/bf02658507 · Cited by 127
Intracellular Defects in Glucose Metabolism in Obese Patients With NIDDM
Kelley, D. E., Mokan, M., & Mandarino, L. J. (1992) · Diabetes · doi:10.2337/diab.41.6.698 · Cited by 121
Lundgren, H., Bengtsson, C., Blohmé, G., Lapidus, L., & Waldenström, J. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01415.x · Cited by 103
Kosáka, K., Kuzuya, T., Hagura, R., & Yoshinaga, H. (1996) · Diabetic Medicine · doi:10.1002/dme.1996.13.s6.109 · Cited by 94
Paolisso, G., Tagliamonte, M. R., Rizzo, M. R., Gualdiero, P., Saccomanno, F., Gambardella, A., Giugliano, D., D'Onofrio, F., & Howard, B. V. (1998) · Diabetologia · doi:10.1007/s001250051041 · Cited by 90
Energy expenditure in humans: effects of dietary fat and carbohydrate
Abbott, W. G. H., Howard, B. V., Ruotolo, G., & Ravussin, É. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.2.e347 · Cited by 84
Reaven, G. M., & Olefsky, J. M. (1977) · Diabetologia · doi:10.1007/bf01219700 · Cited by 83
Analysis of Early-Phase Insulin Responses in Nonobese Subjects With Mild Glucose Intolerance
Yoneda, H., Ikegami, H., Yamamoto, Y., Yamato, E., Cha, T., Kawaguchi, Y., Tahara, Y., & Ogihara, T. (1992) · Diabetes Care · doi:10.2337/diacare.15.11.1517 · Cited by 66
Hales, C. N. (1994) · Diabetologia · doi:10.1007/bf00400840 · Cited by 63
The relationship of insulin response to a glucose stimulus over a wide range of glucose tolerance
Zimmet, P., Whitehouse, S., ALFORD, F. P., & Chisholm, D. J. (1978) · Diabetologia · doi:10.1007/bf01219323 · Cited by 57
Natural History of Impaired Glucose Tolerance: Follow‐up at Joslin Clinic
Warram, J. H., Sigal, R. J., Martin, B. C., Krolewski, A. S., & Soeldner, J. S. (1996) · Diabetic Medicine · doi:10.1002/dme.1996.13.s6.40 · Cited by 47
Mackie, A. D. R., Doddridge, M., Gamsu, H. R., Brudenell, J. M., Nicolaides, K. H., & Drury, P. (1996) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199601)13:1 · Cited by 47
Insulin Secretion and Insulin Sensitivity in People with Impaired Glucose Tolerance
Pimenta, W. P., Mitrakou, A., Jensen, T., Yki-Järvinen, H., Daily, G. M., & Gerich, J. E. (1996) · Diabetic Medicine · doi:10.1002/dme.1996.13.s6.33 · Cited by 43
Body fat distribution and energy metabolism in obese men and women.
Tataranni, P. A., Larson, D. E., & Ravussin, É. (1994) · Journal of the American College of Nutrition · doi:10.1080/07315724.1994.10718449 · Cited by 38
Nagi, D. K., Knowler, W. C., Charles, M.-A. A., Liu, Q. Z., Hanson, R. L., McCance, D. R., Pettitt, D. J., & Bennett, P. H. (1995) · Diabetologia · doi:10.1007/bf00400093 · Cited by 30
Mott, D. M., Pratley, R. E., & Bogardus, C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1778 · Cited by 11
Self-citation
Research works printed but not linked: 6
- 1998, Diabetes Care, 21(Suppl. 1), S5
- DeFronzo, 1997, Diabetes Reviews, 5, 177
- Abbott, 1990, Am J Physiol, 258, E347
- Bogardus, 1984, J Clin Invest, 78, 1568
- Schwartz, 1995, J Clin Endocrinol Metab, 80, 1571
- Luzi, 1989, Am J Physiol, 257, E241
Cited by
Sorted by citations
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Zheng, Y., Ley, S. H., & Hu, F. B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.151 · Cited by 5,697
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Self-citationPathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
“Over 90% of diabetes mellitus cases are T2DM, a condition marked by deficient insulin secretion by pancreatic islet β-cells, tissue insulin resistance (IR) and an inadequate compensatory insulin secretory response [2,3].”
BackgroundGlycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Metadata
- Authors
- Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Weyer, Christian
- Venue
- Journal of Clinical Investigation
- Published
- 1999-09-15
- Volume
- 104
- Issue
- 6
- Pages
- 787-794
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408438
- OpenAlex
- W2077149049
- Cited by
- 1,940
- References
- 68
- Citations by year
- 2026: 24 · 2025: 53 · 2024: 53 · 2023: 74 · 2022: 63 · 2021: 80 · 2020: 64 · 2019: 64 · 2018: 61 · 2017: 72 · 2016: 88 · 2015: 81 · 2014: 91 · 2013: 85 · 2012: 83
- FWCI
- 44.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, impaired glucose tolerance, Pima Indians, insulin-stimulated glucose disposal, weight gain, diabetes prevention, pathogenesis
- MeSH terms
- Insulin Secretion, Adult, Anthropometry, Diabetes Mellitus, Type 2, Female, Glucose, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Male, Obesity, Sex Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
